Cartazolate
http://dbpedia.org/resource/Cartazolate an entity of type: Thing
Cartazolate (SQ-65,396) is a drug of the pyrazolopyridine class. It acts as a GABAA receptor positive allosteric modulator at the barbiturate binding site of the complex and has anxiolytic effects in animals. It is also known to act as an adenosine antagonist at the A1 and A2 subtypes and as a phosphodiesterase inhibitor. Cartazolate was tested in human clinical trials and was found to be efficacious for anxiety but was never marketed. It was developed by a team at E.R. Squibb and Sons in the 1970s.
rdf:langString
rdf:langString
Cartazolate
xsd:integer
28642033
xsd:integer
1085850249
rdf:langString
None
xsd:integer
15
xsd:integer
34966
xsd:integer
8184
xsd:integer
33966
xsd:integer
22
rdf:langString
Уthyl 4--1-ethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate
rdf:langString
Uncontrolled
xsd:integer
4
xsd:integer
2
xsd:integer
37015
rdf:langString
O=COCC
xsd:integer
8
rdf:langString
Cartazolate (SQ-65,396) is a drug of the pyrazolopyridine class. It acts as a GABAA receptor positive allosteric modulator at the barbiturate binding site of the complex and has anxiolytic effects in animals. It is also known to act as an adenosine antagonist at the A1 and A2 subtypes and as a phosphodiesterase inhibitor. Cartazolate was tested in human clinical trials and was found to be efficacious for anxiety but was never marketed. It was developed by a team at E.R. Squibb and Sons in the 1970s.
xsd:nonNegativeInteger
6022
xsd:string
34966-41-1
xsd:string
8184
xsd:string
8K93Z46WPY
xsd:string
37015
